Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Insulin Stem Cells Hold Hope for Diabetes Treatment


Related Encyclopedia
 border=
Addison's Disease
Carcinoid Syndrome
Congenital Adrenal Hyperplasia
Cushing's Syndrome
More...

Related Healthscout Videos
 border=
Hope for Diabetes and Lou Gehrig's
Preventing Type 1 Diabetes
Medicine's Next Big Thing? Diabetes Discoveries
Continuous Glucose Monitoring System
More...

Related Animations
 border=
Diabetes
More...

Related Drug Information
 border=
Actonel
Actos
Amaryl
Avandamet
More...

Related News Articles
 border=
Health Tip: Insulin Shots
Pancreas May Be Key to Pregnancy-Linked Diabetes
Adults With Diabetes Doing Better Prevention Job
Most Americans Have Poor 'Eye-Q'
More...

Page:  << Prev | 1 | 2

For this study, published in this week's issue of Proceedings of the National Academy of Sciences, Prockop's team injected human stem cells into mice who had been made diabetic. Another group of mice, the control animals, received no treatment.

Three weeks later, the mice that received the stem cells had higher levels of mouse insulin (not human insulin) than the control mice. "The human cells went to the pancreas and repaired the insulin-producing cells, so the mice began to produce more mouse insulin," Prockop explained. "The human cells went to the pancreas, but it was mouse insulin in the blood stream."

Kulkarni added, "It's intriguing that they enhanced the production of mouse insulin."

Text Continues Below



Some of the human stem cells also evolved into kidney endothelial cells, or cells that line the interior of blood vessels, and were able to stop damage to the part of the kidney that filters blood. "We also saw human cells in the kidney, and they looked as though they repaired damage to the kidney," Prockop said.

Prockop said the group is now preparing for clinical trials with humans, although other experts still have many questions about the potential therapy.

"This is a very exciting story," said Robert Schwartz, director of the Texas A&M Health Science Center Institute of Biosciences and Technology in Houston. "The issue I take with the article is it's a little like a black box in that we don't understand the mechanism involved, although it's clear from the data that here is an important effect. There are big questions. How long does the effect last? We just don't understand the mechanism, but there's something here of great value," he said.

Insulin, a hormone produced in the pancreas, is needed to carry blood sugar to cells for energy. In people with type 1 diabetes, the pancreas no longer makes insulin. In people with type 2 diabetes, insulin is produced, but their bodies don't respond well to it.

More information

For much more on diabetes, head to the American Diabetes Association (www.diabetes.org ).

Page:  << Prev | 1 | 2

Copyright © 2006 ScoutNews, LLC. All rights reserved.
Last updated 11/7/2006

Related Links
 border=
From Healthscout's partner site on diabetes, MyDiabetesCentral.com
UNDERSTAND: Learn the differences between Type 1 and Type 2
DRUGS: Common drugs used to treat diabetes
DIET: Eating right can save your life!





New Features

New ADHD Site!

SOURCES: Darwin Prockop, M.D., Ph.D., director, Center for Gene Therapy, Tulane University Health Sciences Center, New Orleans; Rohit N. Kulkarni, M.D., Ph.D., Section on Cellular and Molecular Physiology, Joslin Diabetes Center, and assistant professor, medicine, Harvard Medical School, Boston; Robert Schwartz, Ph.D., director, Texas A&M Health Science Center Institute of Biosciences and Technology, Houston; Nov. 6-10, 2006, Proceedings of the National Academy of Sciences


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map